ICON Public Limited Company
- ICLR
- NASDAQ
- Medical - Diagnostics & Research
- Clinical Research Services (CRO)
- Drug Development Outsourcing
$168.14
Today −1.20%Quote Oct 19, 2026, 08:00 PM UTC
+2.46%over the last month
Max drawdown −7.9%From 1-month high −4.2%3 months +0.9%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About ICON Public
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies.
Where the money comes from
Q4 2012 revenue $829.5M
- Clinical Research$766.0M92.3%
- Central Laboratory$63.5M7.7%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
40,200
Founded
1989
Market value
$12.97B
Quote Oct 19
Floor
$161.08
4.2% below price
Resistance
$169.03
0.5% above price
Price vs analyst targets
30 analysts
Lowest target
$105.00Highest target
$207.00
$105.00Highest target
$207.00
- Price $168.14
- Average target $173.82
- Analysts' target range
Analysts' average target sits about 3% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ICLRPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free